Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice

被引:11
|
作者
Cho, Min-Chul [1 ,2 ]
Kim, So Young [3 ,4 ]
Jeong, Tae-Dong [5 ,6 ]
Lee, Woochang [5 ,6 ]
Chun, Sail [5 ,6 ]
Min, Won-Ki [5 ,6 ]
机构
[1] Gyeongsang Natl Univ Hosp, Dept Lab Med, Jinju, South Korea
[2] Gyeongsang Natl Univ, Sch Med, Jinju, South Korea
[3] Catholic Univ Korea, Dept Lab Med, Coll Med, Seoul, South Korea
[4] St Pauls Hosp, Seoul, South Korea
[5] Univ Ulsan, Dept Lab Med, Coll Med, Seoul 138736, South Korea
[6] Asan Med Ctr, Seoul 138736, South Korea
关键词
Quality assurance and control; laboratory methods; PROFICIENCY TESTING MATERIAL; FRESH-FROZEN SERUM; AMERICAN-PATHOLOGISTS SURVEYS; OF-THE-ART; INTERLABORATORY HARMONIZATION; COMMUTABILITY; ACCURACY; QUALITY; VERIFICATION; TRUENESS;
D O I
10.1177/0004563214520749
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Verification of new lot reagent's suitability is necessary to ensure that results for patients' samples are consistent before and after reagent lot changes. A typical procedure is to measure results of some patients' samples along with quality control (QC) materials. In this study, the results of patients' samples and QC materials in reagent lot changes were analysed. In addition, the opinion regarding QC target range adjustment along with reagent lot changes was proposed. Patients' sample and QC material results of 360 reagent lot change events involving 61 analytes and eight instrument platforms were analysed. The between-lot differences for the patients' samples ((P)) and the QC materials ((QC)) were tested by Mann-Whitney U tests. The size of the between-lot differences in the QC data was calculated as multiples of standard deviation (SD). The (P) and (QC) values only differed significantly in 7.8% of the reagent lot change events. This frequency was not affected by the assay principle or the QC material source. One SD was proposed for the cutoff for maintaining pre-existing target range after reagent lot change. While non-commutable QC material results were infrequent in the present study, our data confirmed that QC materials have limited usefulness when assessing new reagent lots. Also a 1 SD standard for establishing a new QC target range after reagent lot change event was proposed.
引用
收藏
页码:688 / 694
页数:7
相关论文
共 50 条
  • [21] COMPUTERIZED APPROACH TO STATISTICAL QUALITY-CONTROL FOR RADIOIMMUNOASSAYS IN CLINICAL-CHEMISTRY LABORATORY
    MCDONAGH, BF
    MUNSON, PJ
    RODBARD, D
    COMPUTER PROGRAMS IN BIOMEDICINE, 1977, 7 (03): : 179 - 190
  • [22] Training through malaria research: building capacity in good clinical and laboratory practice in Liberia
    Mayor, Alfredo
    Martinez-Perez, Guillermo
    Tarr-Attia, Christine K.
    Breeze-Barry, Bondey
    Sarukhan, Adelaida
    Meyer Garcia-Sipido, Ana
    Carlos Hurtado, Juan
    Peter Lansana, Dawoh
    Casamitjana, Nuria
    MALARIA JOURNAL, 2019, 18 (1)
  • [23] GOOD CLINICAL-PRACTICE - QUALITY-CONTROL OF BIOLOGICAL ASSAYS IN HOSPITAL LABORATORY
    GARNIER, JP
    DREUX, C
    THERAPIE, 1991, 46 (01): : 61 - 64
  • [24] Good practice in laboratory diagnostic andrology: Association of Reproductive and Clinical Scientists guidelines 2024
    Gallagher, Meurig T.
    Roxburgh, Emily
    Bennett, Gwen
    Parker, Susan
    Kirkman-Brown, Jackson C.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2024, 49 (06)
  • [25] Training through malaria research: building capacity in good clinical and laboratory practice in Liberia
    Alfredo Mayor
    Guillermo Martínez-Pérez
    Christine K. Tarr-Attia
    Bondey Breeze-Barry
    Adelaida Sarukhan
    Ana Meyer García-Sípido
    Juan Carlos Hurtado
    Dawoh Peter Lansana
    Núria Casamitjana
    Malaria Journal, 18
  • [26] ANALYSIS OF SHORT-TERM VARIATION AND LONG-TERM DRIFT DURING REAGENT KIT LOT CHANGE IN AN NABL ACCREDITED CLINICAL BIOCHEMISTRY LABORATORY
    Ambade, Vivek
    Misra, Pratibha
    Vashum, Yaongamphi
    Sharma, Mukul
    Mukherjee, Bhasker
    Bhatia, Kapil
    Puliyath, Manoj
    Rasu, Ponnaiah
    Berthwal, Indra Prakash
    Kandi, Sibin Madathan
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2021, 40 (01) : 92 - 98
  • [27] Developing approaches to reagent lot-to-lot validation for an integrated health network of ortho-clinical vitros chemistry analyzers in suburban centers
    To, M.
    Goudreau, B.
    Raizman, J.
    Higgins, T.
    Tsui, A.
    CLINICA CHIMICA ACTA, 2022, 530 : S249 - S250
  • [28] Developing approaches to reagent lot-to-lot validation for an integrated health network of Ortho-Clinical VITROS chemistry analyzers in suburban centers
    To, Michelle
    Bobbi-Lynn, Goudreau
    Raizman, Josh
    Higgins, Trefor
    Tsui, Albert
    CLINICAL BIOCHEMISTRY, 2020, 86 : 75 - 75
  • [29] Implementation of Good Clinical Laboratory Practice in an Immunology Basic Research Laboratory: The KEMRI-Wellcome Trust Research Laboratories Experience
    Gumba, Horace
    Musyoki, Jennifer
    Mosobo, Moses
    Lowe, Brett
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 151 (03) : 270 - 274
  • [30] Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice?
    Hortin, GL
    CLINICAL CHEMISTRY, 2005, 51 (01) : 3 - 5